Biotech · Public company · Cambridge, MA, US
Apnimed, Inc.
Ticker APMD · SEC CIK 0001745648
Track this companyFree. Adds Apnimed, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials161 recruiting or active
Pipeline programs24From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline24
- AD109Phase 3 · OSAClinicalTrials.gov · fetched Nov 12, 2026
- Aroxybutynin and AtomoxetinePhase 3 · OSAClinicalTrials.gov · fetched Nov 12, 2026
- AD036Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD036 Dose 1Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD036 Dose 2Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD036 Dose 3Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD109Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD109Phase 2 · OSA - Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD109 dose1- APhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD109 dose2- BPhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD113Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD182Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD313Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD504Phase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AD504Phase 2 · OSA - Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- AtomoxetinePhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- Atomoxetine HydrochloridePhase 2 · OSA - Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- Digit System Substitution TestPhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- Dosing 1: AtomoxetinePhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- Period APhase 2 · OSAClinicalTrials.gov · fetched Nov 12, 2026
- Period BPhase 2 · OSAClinicalTrials.gov · fetched Nov 12, 2026
- Period CPhase 2 · OSAClinicalTrials.gov · fetched Nov 12, 2026
- PolysomnographyPhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- R-oxybutyninPhase 2 · Obstructive Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- Adherence to Health Coaching with Wearable Devices: Enhancing Patient Engagement and OutcomesNA · UNKNOWN · started Aug 30, 2024ClinicalTrials.gov NCT06525337 · fetched Nov 12, 2026
- Continuation Protocol for Obstructive Sleep Apnea (OSA)PHASE3 · ENROLLING_BY_INVITATION · started Jul 3, 2024ClinicalTrials.gov NCT06566820 · fetched Nov 12, 2026
- Study That Tests AD109 in Patients Taking GLP-1 DrugsPHASE2 · COMPLETED · started May 20, 2024ClinicalTrials.gov NCT06400615 · fetched Nov 12, 2026
- Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)PHASE3 · COMPLETED · started Sep 16, 2023ClinicalTrials.gov NCT05813275 · fetched Nov 12, 2026
- Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)PHASE3 · COMPLETED · started Aug 28, 2023ClinicalTrials.gov NCT05811247 · fetched Nov 12, 2026
- AD816 Crossover StudyPHASE2 · COMPLETED · started Apr 28, 2023ClinicalTrials.gov NCT05793684 · fetched Nov 12, 2026
- Parallel Arm Trial of AD109 and AD504 In Patients With OSAPHASE2 · COMPLETED · started Nov 29, 2021ClinicalTrials.gov NCT05071612 · fetched Nov 12, 2026
- Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)PHASE1_PHASE2 · COMPLETED · started Oct 19, 2021ClinicalTrials.gov NCT05101122 · fetched Nov 12, 2026
- Trial of AD113 and Atomoxetine in OSA Patients With HypertensionPHASE2 · COMPLETED · started Jul 31, 2021ClinicalTrials.gov NCT04905979 · fetched Nov 12, 2026
- AD109 Dose Finding in Mild to Moderate OSAPHASE2 · COMPLETED · started Dec 22, 2020ClinicalTrials.gov NCT04631107 · fetched Nov 12, 2026
- Pharmacological Intervention for Symptomatic Mild Sleep Disordered BreathingPHASE2 · COMPLETED · started Dec 2, 2020ClinicalTrials.gov NCT04611750 · fetched Nov 12, 2026
- Crossover Trial of AD182 and AD504 in Obstructive Sleep ApneaPHASE2 · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04645524 · fetched Nov 12, 2026
- Crossover Trial of AD109 in Obstructive Sleep ApneaPHASE2 · COMPLETED · started Oct 27, 2020ClinicalTrials.gov NCT04580394 · fetched Nov 12, 2026
- Crossover Trial of AD036 in Obstructive Sleep ApneaPHASE2 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04445688 · fetched Nov 12, 2026
- Trial of AD036 in Obstructive Sleep ApneaPHASE2 · COMPLETED · started Mar 7, 2019ClinicalTrials.gov NCT03845023 · fetched Nov 12, 2026
- Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep ApneaPHASE1_PHASE2 · COMPLETED · started Jan 14, 2019ClinicalTrials.gov NCT03892772 · fetched Nov 12, 2026
SEC filings6
- 10-Q · 10-QSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 424B4 · 424B4SEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Jul 10, 2026 · fetched Nov 12, 2026